Rallybio Announces Retirement of Jeffrey Fryer, CPA, Chief Financial Officer
apnews.com
science
2022-06-02 12:32:53

NEW HAVEN, Conn.--(BUSINESS WIRE)--Jun 2, 2022--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced that Jeffrey Fryer, CPA, will retire from his position as Chief Financial Officer (CFO). Mr. Fryer will continue to serve as Rallybio's CFO until a new CFO has been appointed and will retire from the Company following a transition period.
